Dr. Bansal is board certified in Obstetrics and Gynecology and Gynecologic Oncology.  She received her medical degree from Rutgers New Jersey Medical School and went on to complete her residency in Obstetrics and Gynecology at Columbia Presbyterian Medical Center.  She then completed her fellowship in Gynecologic Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. 

Dr. Bansal is skilled in the treatment of complex gynecologic diseases such as ovarian cysts and endometriosis.  She has a broad range of experience in the treatment of gynecologic malignancies including ovarian, uterine, cervical, vulvar and vaginal cancers.  She also treats preinvasive gynecologic diseases such as carcinoma in situs of the vulva, vagina and cervix.  She has a special interest in minimally invasive surgery and is experienced in advanced laparoscopic and robotic surgical techniques. 

Dr. Bansal is trained in the comprehensive treatment for gynecologic malignancies including surgery, and the delivery of chemotherapy.  She is an active participant in the clinical trials program.  She is also an advocate for the quality of life and well being of her patients. 

Dr. Bansal is an active full member of the Society of Gynecologic Oncologists.

Dr. Bansal is currently seeing patients in the Eastchester Practice Location and at Montefiore in Hartsdale.

Eastchester Practice Office:

1695 Eastchester Road, Suite 601

Bronx, NY 10461

718-405-8082

Hartsdale Practice:

141 South Central Ave, Suite 201

Hartsdale, NY 10530

914-997-1087

Hodeib M, Tsui I, Sinno A, Bansal N, Cohen JG.  Adult Granulosa Cell Tumor of the Ovary: Initial Evaluation and Current Treatment Paradigm.  J Cancer Res 2017; 1 (1): 006-018.

Bansal N, Marchion DC, Bicaku E, Xiong Y, Chen N, Stickles XB, Sawah EA, Wenham RM, Apte SM, Gonzalez-Bosquet J, Judson PL, Hakam A, Lancaster JM.BAD pathway kinases and phosphatases: Bcl2 antagonists of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin. J Gynecol Oncol 2012; 23(1): 35-42.

Ramirez I, Bansal N, Hoffman M. Peritoneal Catheter Site Metastasis in a Patient With Advanced Ovarian Cancer. Am J Hosp Palliat Care 2012;29(3):241-2.

Marchion DC, Cottrill HM, Xiong Y, Chen N, Bicaku E, Fulp WJ, Bansal N, Chon HS, Stickles XB, Kamath SG, Hakam A, Li L, Su D, Moreno C, Judson PL, Berchuck A, Wenham RM, Apte SM, Gonzalez-Bosquet J, Bloom GC, Eschrich SA, Sebti S, Chen DT, Lancaster JM.  BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival. Clin Cancer Res 2011;17(19):6356-66.

Bansal N, Hoffman M.  Bladder perforation in a patient with recurrent epithelial ovarian cancer after treatment with bevacizumab.  Gynecol Oncol 2011; 120(2):313-4.

Bansal N, Yendluri V, Wenham R.  The molecular biology of endometrial cancers and the implications for pathogenesis, classification and targeted therapies.  Cancer Control 2009; 16(1): 8-1

Bansal N, Roberts W, Apte S, Lancaster JM, Wenham R.  Electrothermal bipolar coagulation decreases the rate of blood transfusions for pelvic exenterations.  J Surg Oncol 2009 Aug 20.

Bansal N, Herzog TJ, Shaw RE, Burke WM, Deutsch I, Wright JD.  Primary therapy for early stage cervical cancer: radical hysterectomy versus radiation. Am J Obstet Gynecol 2009; 201(5):485.e1-9.

Wethington SL, Herzog TJ, Seshan VE, Bansal N, Schiff PB, Burke WM, Cohen CJ, Wright JD.Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer.  Cancer 2008;113(12):3298-3306.

Bansal N, Herzog TJ, Cohen C, Wright JD.  Natural history of established low grade cervical intraepithelial (CIN 1) lesions.  Anticancer Res 2008;28(3B):1763-6.

Bansal N, Herzog TJ, Cohen C, Wright JD.  The utility of pre-operative endometrial sampling for the detection of uterine sarcomas.  Gynecol Oncol 2008;110(1):43-8.

Bansal N, Burke WM, Wethington SL, Cohen CJ, Herzog TJ, Wright JD.  The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies.  Gynecol Oncol 2008; 111(2): 208-212.

Bansal N, Herzog TJ, Seshan VE, Schiff PB, Burke WM, Cohen CJ, Wright JD.  Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.  Obstet Gynecol 2008;112(1):64-70.

Bansal N, Cohen C, Shah JN, Schiff PB, Herzog TJ, Wright JD.  Early metastatic spread after a complete response for locally advanced vulvar cancer treated with neoadjuvant chemoradiation. J Reprod Med 2008; 53(9):700-2.

Bansal N.  The day I made a difference.  Obstet Gynecol 2009; 113(5):1149-50.

Bansal N.  For SC, who reminded me of the purpose of the pursuit of medicine.  Obstet Gynecol 2008; 111(5): 1236-7.

Bansal N, Wright JD, Herzog TJ.  Uterine leiomyosarcomas: a review. Women’s Oncology Review 2006; 6(3-4):121-126.

Bansal N, Herzog TJ, Wright JD.  A retrospective analysis of bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma.  American Journal of Hematology/Oncology 2006; 5(12):2-4.

Bansal N, Herzog TJ.  Fertility options in women with gynecologic malignancies.  Women's Oncology Review 2006; 5(4):185-191.